Search

Search Constraints

You searched for: Author/Creator Ott, Peter

Search Results

14. O01 Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial. (20th September 2022)

15. Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation. Issue 2 (11th November 2022)